Legendary Stock Picker: “Forget Nvidia, Buy This Instead”

Eric Fry will show you how “the next $1 trillion AI stock” could hand you up to 40 years of Nvidia gains in the coming months.

Tue, May 21 at 7:00PM ET
 
 
 
 

Today's Market

Why are stocks up (or down) and what does the latest Nvidia news mean? Today’s Market will answer those questions and keep you informed about big stock market movers. We’ll also tell you about the latest Fed moves, what stocks Warren Buffett is buying, and which stocks look primed for a short squeeze. Today’s Market is the perfect pairing of InvestorPlace’s expert financial advice and critical stock and crypto news.

Top Stories

Market News

F Stock Alert: What to Know as Ford Hikes F-150 Lightning Prices

Ford is raising the price of the F-150 Lighting again, pushing F stock down. Here's what this news means for investors.

Why Is Coinbase (COIN) Stock Down Today?

Coinbase stock is making new 52-week lows. On Friday, COIN stock is under pressure after an unfavorable ruling from a federal judge.

Former Nikola CEO Mark Russell Keeps Selling NKLA Stock

Since Sept. 15, former Nikola CEO Mark Russell has sold 75,000 shares of NKLA stock nearly every day. What's going on?

LCID Stock News: Lucid Opens Third European Retail Location

Today, investors in Lucid Group and LCID stock received some promising news, but that wasn't enough to take shares higher.

PLTR Stock Alert: What to Know About Palantir’s Newest Partnership

Today, investors in Palantir and PLTR stock are in selling mode, despite what appears to be a positive catalyst for the company.

What Outside App Stores Will Mean for Apple (AAPL) Stock

Though the EU’s mandate to force Apple to accept third-party app stores doesn’t appear problematic, AAPL stock still presents some concerns.

DNUT Stock: 12 Takeaways From Krispy Kreme’s Investor Day

Krispy Kreme (DNUT) stock is on the move Friday as investors react to the latest news from the company's investor day event.

Why Are Chinese Education Stocks TAL, EDU Up Today?

Chinese education stocks are on the rise Friday despite a lack of news specifically related to companies in this sector.

Applied UV (AUVI) Stock Soars on Strategic Partnership News

Applied UV (AUVI) stock is on the rise Friday after announcing a strategic partnership with Canon subsidiary Canon Virginia.

T. Rowe Price Capitulates on Carvana (CVNA) Stock

As of Nov. 30, T. Rowe Price held just 20,982 shares of CVNA stock. The firm previously owned 13.44 million shares.

Why Is Agrify (AGFY) Stock Down 50% Today?

Agrify (AGFY) stock is on the move Friday as the company's shares take a beating after revealing details of a stock offering.

Altaris Capital Is Acquiring Trean Insurance Group. TIG Stock Is Soaring 90%

Trean Insurance Group is about to be taken private by Altaris Capital. Here's why this news is sending TIG stock soaring today.

OCGN Stock Alert: What to Know About Ocugen’s Latest Phase 3 Clinical Trial

OCGN stock fell into the red despite Ocugen's success in advancing a regenerative cell therapy product evaluation.

Bitcoin Drops as Mazars Group Steps Back From Crypto Clients

An accounting firm's concerns about the solvency of crypto-related exchanges is weighing on the Bitcoin price today.

Why Is Novavax (NVAX) Stock Down 10% Today?

Novavax is conducting a public offering of 6.5 million shares. Here's why the news is pushing NVAX stock down.

COSM Stock Alert: What to Know As Cosmos’ Reverse Stock Split Takes Effect

Cosmos (COSM) stock is on the move Friday as the healthcare company undergoes a name change and a reverse stock split today.

Dear Camber Energy (CEI) Stock Fans, Mark Your Calendars for Dec. 30

Shares of CEI stock are in the red after Camber Energy announced that it would pursue a 1-for-50 reverse stock split.

AVYA Stock Alert: Is Avaya Holdings Nearing Bankruptcy?

Avaya (AVYA) stock is falling hard on Friday following recent reports that the company is closing in on a bankruptcy filing.

Why Is Exact Sciences (EXAS) Stock Up 23% Today?

Exact Sciences (EXAS) stock is on the rise Friday following news that Guardant Health's (GH) clinical trial didn't go as well as expected.